关注
Isabel Belinchon Romero
Isabel Belinchon Romero
Dermatóloga, Hospital General Universitario Dr Balmis.ISABIAL, Universidad Miguel Hernández
在 umh.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials
I Garcia-Doval, G Carretero, F Vanaclocha, C Ferrandiz, E Daudén, ...
Archives of dermatology 148 (4), 463-470, 2012
2082012
Consensus document on the evaluation and treatment of moderate‐to‐severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology
E Daudén, L Puig, C Ferrándiz, JL Sánchez‐Carazo, ...
Journal of the European Academy of Dermatology and Venereology 30, 1-18, 2016
1262016
Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM registry
P Dávila-Seijo, E Dauden, MA Descalzo, G Carretero, JM Carrascosa, ...
Journal of Investigative Dermatology 137 (2), 313-321, 2017
1202017
Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry
JM Carrascosa, M Vilavella, I Garcia‐Doval, G Carretero, F Vanaclocha, ...
Journal of the European Academy of Dermatology and Venereology 28 (7), 907-914, 2014
902014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the …
G Carretero, C Ferrandiz, E Dauden, F Vanaclocha Sebastian, ...
Journal of the European Academy of Dermatology and Venereology 29 (1), 156-163, 2015
732015
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry
C Medina, G Carretero, C Ferrandiz, E Dauden, F Vanaclocha, ...
Journal of the European Academy of Dermatology and Venereology 29 (5), 858-864, 2015
602015
Estudio bibliométrico de la revista Actas Dermo-Sifiliográficas (1984-2003) II. Análisis de las referencias bibliográficas
J Miralles, JM Ramos, R Ballester, I Belinchón, A Sevila, M Moragón
Actas Dermo-Sifiliográficas 96 (9), 563-571, 2005
592005
Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and …
L Puig, JM Carrascosa, I Belinchón, V Fernández-Redondo, G Carretero, ...
Actas Dermo-Sifiliográficas (English Edition) 104 (6), 488-496, 2013
572013
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases …
E Daudén, G Carretero, R Rivera, C Ferrándiz, M Llamas-Velasco, ...
Journal of the American Academy of Dermatology 83 (1), 139-150, 2020
562020
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: A study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in …
AI Sánchez‐Moya, I García‐Doval, G Carretero, J Sánchez‐Carazo, ...
Journal of the European Academy of Dermatology and Venereology 27 (11), 1366 …, 2013
552013
Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia
B Sanchez-Gonzalez, JC Pascual-Ramirez, P Fernandez-Abellan, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2446-2446, 2003
542003
Epidemiology of leprosy in Spain: the role of the international migration
JM Ramos, D Romero, I Belinchón
PLoS neglected tropical diseases 10 (3), e0004321, 2016
522016
Gender differential on characteristics and outcome of leprosy patients admitted to a long-term care rural hospital in South-Eastern Ethiopia
JM Ramos, M Martínez-Martín, F Reyes, D Lemma, I Belinchón, ...
International Journal for Equity in Health 11, 1-7, 2012
502012
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children
A Tagarro, E Cobos-Carrascosa, S Villaverde, FJ Sanz-Santaeufemia, ...
European journal of pediatrics, 1-11, 2022
452022
Evolution of cooperation patterns in psoriasis research: Co-authorship network analysis of papers in Medline (1942–2013)
G González-Alcaide, J Park, C Huamani, I Belinchon, JM Ramos
PloS one 10 (12), e0144837, 2015
432015
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective …
I García‐Doval, MV Hernández, F Vanaclocha, A Sellas, P de la Cueva, ...
British Journal of Dermatology 176 (3), 643-649, 2017
422017
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: a cross-sectional study in clinical practice
JM Carrascosa, I Garcia-Doval, B Pérez-Zafrilla, G Carretero, ...
Journal of Dermatological Treatment 26 (6), 502-506, 2015
422015
Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis
C Ferrándiz, E Fonseca-Capdevila, A García-Diez, C Guillén-Barona, ...
Actas Dermo-Sifiliográficas (English Edition) 105 (4), 378-393, 2014
412014
[Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of …
JM Carrascosa, L Puig, IB Romero, L Salgado-Boquete, E Del Alcázar, ...
Actas dermo-sifiliograficas 113 (3), T261-T277, 2022
362022
Tinea capitis in schoolchildren in a rural area in southern E thiopia
M Leiva‐Salinas, I Marin‐Cabanas, I Betlloch, A Tesfasmariam, F Reyes, ...
International Journal of Dermatology 54 (7), 800-805, 2015
362015
系统目前无法执行此操作,请稍后再试。
文章 1–20